The Walkup Law Firm has won the first DePuy hip implant lawsuit against Johnson & Johnson. A Los Angeles County Jury awarded Loren Kransky $8.3 million for the damages he suffered after receiving a defective DePuy ASR hip implant. The case was tried by Walkup partners Mike Kelly, Matthew Davis and Khaldoun Baghdadi. There are…
Drugmaker Biogen Idec recently announced that one of its new pharmaceuticals has proven to be ineffective on patients who suffer from amyotrophic lateral sclerosis (ALS). The drugmaker’s Phase 3 EMPOWER trial found that the drug dexpramipexole failed to show efficacy in function and patient survival. This means that the pharmaceutical is defective and that the…
A nationwide investigation continues into a fungal meningitis outbreak that has sickened at least 424 people and killed 31 in 19 states, including California. The outbreak is linked to contaminated steroid injections from Massachusetts-based New England Compounding Center. The specialty pharmacy has been on the radar of health and safety inspectors for years but always…
The Food and Drug Administration recently announced a recall of organic peanut butter and a salted-in shell product due to concerns of salmonella contamination. The products were manufactured by Los Angeles-based Torn and Glasser, Inc. The contaminated products were sold under a variety of labels including Gless Ranch, Sun Harvest, Sprouts, and Torn and Glasser….
Pharmaceutical giant GlaxoSmithKline was recently slapped with a $3 billion fine for illegally marketing a variety of drugs for unapproved, off-label uses. Authorities brought criminal and civil fines against GSK for its marketing of Paxil, Webutrin, Avandia, and other drugs, which may have exposed many patients to unnecessary personal injuries. Authorities specifically accuse GSK of…
Pharmaceutical giant Johnson & Johnson may have to pay over $1.8 billion to settle claims related to its marketing of its blockbuster antipsychotic drug Risperdal. The drug was once Johnson & Johnson’s best-selling drug, generating over $24 billion in 2003. Risperdal was approved by the Food and Drug Administration to treat psychotic disorders, but the…
Federal safety regulators have begun a probe into a possible bus defect which may have contributed to several serious recent bus accidents. Bus accidents are among the most serious types of traffic incidents in California and seriously many people every year. The federal probe started when the National Highway Traffic Safety Administration received a complaint…
A recent investigation by Consumer Reports indicates that medical devices such as artificial hip implants are often not tested thoroughly enough to protect consumers. The Consumer Reports investigation suggests that metal-on-metal hip implants were rushed to the marketplace without adequate safety testing to ensure that implant recipients would not be harmed. Metal-on-metal hip implants made…
In our last post we discussed the pending litigation against one of the nation’s largest medical device manufacturers arising out of the off-label use of its bone grafts. Medtronic’s INFUSE Bone Grafts were used in several types of spinal surgeries without approval by the Food and Drug Administration. As a result, many patients now suffer…
When the makers of a drug or medical device pay doctors to provide research on the safety and efficacy of the treatment, can the results be trusted? In the case of Medtronic’s bone growth product, INFUSE, there is major controversy over the fact the drug and device maker paid researchers a substantial amount to identify…
Lawyers Who Know
How
to Win Your Case
